PERIDANS: Estimation of Pain During Epidural Analgesia During Labor

Sponsor
Centre Hospitalier Universitaire de Saint Etienne (Other)
Overall Status
Completed
CT.gov ID
NCT02551354
Collaborator
(none)
40
1
1
3.9
10.1

Study Details

Study Description

Brief Summary

Epidural regional anesthesia is a technique to eliminate or lessen pain during obstetric labor and childbirth. It consists in establishing a catheter into the epidural space and to block the transmission of pain sensations by injecting a local anesthetic and an opioid. In 10-25% of cases the epidural does not give perfect results, causing it to test its effectiveness, which is mainly done by questioning the patient on mitigation or disappearance of pain. This collaboration of patients is sometimes limited in our care structure by the inability to assess or express the pain, mainly due to cultural differences or language barriers, which can represent up to 15% of women in our institution. This led to develop objective measures of pain techniques used at the bedside.

Pupil diameter (PD) varies under the double influence of sympathetic system (Σ), dilator of the pupil, and parasympathetic system (pΣ).

The PD increases in response to painful stimulation, in proportion to the intensity of the nociceptive stimulus. This variation of PD has been proposed as a means of evaluation of pain in patients under general anesthesia, but has been little studied in conscious subjects.

There are other permanent changes in the PD, due to constant interaction between Σ and pΣ systems. Few data have been published to date on this PD variability (PDV).

Condition or Disease Intervention/Treatment Phase
  • Device: Portable video pupillometer
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Estimation of Pain During Epidural Analgesia During Labor - a Monocentric Study
Study Start Date :
Nov 1, 2012
Actual Primary Completion Date :
Mar 1, 2013
Actual Study Completion Date :
Mar 1, 2013

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patients

Pain assess by : Visual Analogic Scale (VAS). Portable video pupillometer

Device: Portable video pupillometer
Portable video pupillometer measures pupil diameter (PD) in patient during obstetrical labor

Outcome Measures

Primary Outcome Measures

  1. Pupil diameter variability [From baseline to fifteen minutes after start of Epidural regional anesthesia]

    Compare Pupil Diameter Variability (PDV) measured before Epidural regional anesthesia and after Epidural regional anesthesia. PDV is aera under the curve of Pupil Diameter from start of the contraction (baseline) to time to peak of the contraction.

Secondary Outcome Measures

  1. pupil diameter [From baseline to fifteen minutes after start of Epidural regional anesthesia]

    Compare the Pupil Diameter measured five seconds after time to peak of contraction before Epidural regional anesthesia and after Epidural regional anesthesia

  2. Visual Analogic Scale (VAS) [From baseline to fifteen minutes after start of Epidural regional anesthesia]

    Compare the VAS measured at the end of contraction before Epidural regional anesthesia and after Epidural regional anesthesia.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 45 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Obstetrical Labor

  • Able to rate their pain using VAS

  • dilatation of the cervix under 6 centimeters

  • Written consent

Exclusion Criteria:
    • Not having a anesthesia consultation during the 48 hours before delivery
  • With a contra-indication for an epidural

  • To which an incident occurred during a previous epidural using a medication used in the study

  • Operated a unilateral or bilateral ocular surgery modifying the possibilities of variation of pupil diameter

  • general anesthesia in the seven days preceding delivery

  • Carry a pacemaker or heart grafted

  • Having Parkinson's disease history, insulin or non-insulin diabetes or chronic alcoholism

  • Having cardiac arrhythmia (atrial fibrillation or frequent extrasystoles)

  • Treated for hypertension by receptor antagonists of angiotensin type 2

  • anti-arrhythmic treatment or blocker,

  • Refusing to participate in the study

  • With a contra-indication for the use of ropivacaine and sufentanil.

Contacts and Locations

Locations

Site City State Country Postal Code
1 CHU Saint-Etienne Saint-Etienne France 42055

Sponsors and Collaborators

  • Centre Hospitalier Universitaire de Saint Etienne

Investigators

  • Principal Investigator: David Charier, MD, CHU Saint-Etienne

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire de Saint Etienne
ClinicalTrials.gov Identifier:
NCT02551354
Other Study ID Numbers:
  • 1208078
First Posted:
Sep 16, 2015
Last Update Posted:
Sep 16, 2015
Last Verified:
Sep 1, 2015
Keywords provided by Centre Hospitalier Universitaire de Saint Etienne

Study Results

No Results Posted as of Sep 16, 2015